MaxCyte, Inc. Operating Lease Cost
MaxCyte, Inc. (MXCT) reported Operating Lease Cost of $536.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseCost · last filed 2026-08-13
- MaxCyte, Inc. operating lease, cost for the quarter ending 2026-06-30 was $536.00K, a 0.00% change year-over-year.
- MaxCyte, Inc. operating lease, cost for the quarter ending 2026-03-31 was $536.00K, a 5.10% increase year-over-year.
- MaxCyte, Inc. operating lease, cost for the quarter ending 2025-12-31 was $535.00K, a 21.32% increase year-over-year.
- MaxCyte, Inc. operating lease, cost for the quarter ending 2025-09-30 was $536.00K, a 21.54% increase year-over-year.
- MaxCyte, Inc. operating lease, cost for fiscal 2025 was $2.12M, a 20.01% increase from fiscal 2024.
- MaxCyte, Inc. operating lease, cost for fiscal 2024 was $1.76M, a 8.89% increase from fiscal 2023.
- MaxCyte, Inc. operating lease, cost for fiscal 2023 was $1.62M, a 0.25% decline from fiscal 2022.
- MaxCyte, Inc. operating lease, cost for fiscal 2022 was $1.62M, a 127.42% increase from fiscal 2021.
| Period end | Operating Lease, Cost 3 month | Operating Lease, Cost 3 month as first filed | Operating Lease, Cost 6 month | Operating Lease, Cost 6 month as first filed | Operating Lease, Cost 9 month | Operating Lease, Cost 9 month as first filed | Operating Lease, Cost 12 month | Operating Lease, Cost 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $536.00K 10-Q · filed 2026-08-13 | $1.07M 10-Q · filed 2026-08-13 | $1.61M derived: sum of 3 quarters · filed 2026-08-13 | $2.14M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | $536.00K 10-Q · filed 2026-05-13 | $1.07M derived: sum of 2 quarters · filed 2026-05-13 | $1.61M derived: sum of 3 quarters · filed 2026-05-13 | $2.14M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | $535.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $1.07M derived: sum of 2 quarters · filed 2026-03-25 | $1.61M derived: sum of 3 quarters · filed 2026-08-13 | $2.12M 10-K · filed 2026-03-25 | ||||
| 2025-09-30 | $536.00K 10-Q · filed 2025-11-13 | $1.07M derived: sum of 2 quarters · filed 2026-08-13 | $1.58M 10-Q · filed 2025-11-13 | $2.02M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | $536.00K 10-Q · filed 2026-08-13 | $1.05M 10-Q · filed 2026-08-13 | $1.49M derived: sum of 3 quarters · filed 2026-08-13 | $1.93M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-03-31 | $510.00K 10-Q · filed 2026-05-13 | $951.00K derived: sum of 2 quarters · filed 2026-05-13 | $1.39M derived: sum of 3 quarters · filed 2026-05-13 | $1.83M derived: sum of 4 quarters · filed 2026-05-13 | ||||
| 2024-12-31 | $441.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $882.00K derived: sum of 2 quarters · filed 2026-03-25 | $1.32M derived: sum of 3 quarters · filed 2026-03-25 | $1.76M 10-K · filed 2026-03-25 | ||||
| 2024-09-30 | $441.00K 10-Q · filed 2025-11-13 | $882.00K derived: sum of 2 quarters · filed 2025-11-13 | $1.32M 10-Q · filed 2025-11-13 | $1.74M derived: sum of 4 quarters · filed 2025-11-13 | ||||
| 2024-06-30 | $441.00K 10-Q · filed 2025-08-06 | $882.00K 10-Q · filed 2025-08-06 | $1.30M derived: sum of 3 quarters · filed 2025-08-06 | $1.65M derived: sum of 4 quarters · filed 2025-08-06 | ||||
| 2024-03-31 | $441.00K 10-Q · filed 2025-05-08 | $855.00K derived: sum of 2 quarters · filed 2025-05-08 | $1.21M derived: sum of 3 quarters · filed 2025-05-08 | $1.57M derived: sum of 4 quarters · filed 2025-05-08 | ||||
| 2023-12-31 | $414.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | $772.00K derived: sum of 2 quarters · filed 2025-03-11 | $1.13M derived: sum of 3 quarters · filed 2025-03-11 | $1.62M 10-K · filed 2025-03-11 | ||||
| 2023-09-30 | $358.00K 10-Q · filed 2024-11-06 | $358.20K 10-Q · filed 2023-11-08 | $716.00K derived: sum of 2 quarters · filed 2024-11-06 | $1.21M 10-Q · filed 2024-11-06 | $1.21M 10-Q · filed 2023-11-08 | $1.56M derived: sum of 4 quarters · filed 2024-11-06 | ||
| 2023-06-30 | $358.00K 10-Q · filed 2024-08-06 | $358.20K 10-Q · filed 2023-08-09 | $848.00K 10-Q · filed 2024-08-06 | $847.60K 10-Q · filed 2023-08-09 | $1.21M derived: sum of 3 quarters · filed 2024-08-06 | $1.60M derived: sum of 4 quarters · filed 2024-08-06 | ||
| 2023-03-31 | $489.00K 10-Q · filed 2024-05-07 | $489.40K 10-Q · filed 2023-05-10 | $848.10K derived: sum of 2 quarters · filed 2024-05-07 | $1.25M derived: sum of 3 quarters · filed 2024-05-07 | $1.70M derived: sum of 4 quarters · filed 2024-05-07 | |||
| 2022-12-31 | $359.10K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12 | $757.90K derived: sum of 2 quarters · filed 2024-03-12 | $1.21M derived: sum of 3 quarters · filed 2024-03-12 | $1.62M 10-K · filed 2024-03-12 | $1.62M 10-K · filed 2023-03-15 | |||
| 2022-09-30 | $398.80K 10-Q · filed 2023-11-08 | $848.60K derived: sum of 2 quarters · filed 2023-11-08 | $1.26M 10-Q · filed 2023-11-08 | $1.46M derived: sum of 4 quarters · filed 2023-11-08 | ||||
| 2022-06-30 | $449.80K 10-Q · filed 2023-08-09 | $866.10K 10-Q · filed 2023-08-09 | $1.06M derived: sum of 3 quarters · filed 2023-08-09 | $1.23M derived: sum of 4 quarters · filed 2023-08-09 | ||||
| 2022-03-31 | $416.30K 10-Q · filed 2023-05-10 | $609.30K derived: sum of 2 quarters · filed 2023-05-10 | $783.50K derived: sum of 3 quarters · filed 2023-05-10 | $957.70K derived: sum of 4 quarters · filed 2023-05-10 | ||||
| 2021-12-31 | $193.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | $367.20K derived: sum of 2 quarters · filed 2023-03-15 | $541.40K derived: sum of 3 quarters · filed 2023-03-15 | $714.10K 10-K · filed 2023-03-15 | ||||
| 2021-09-30 | $174.20K 10-Q · filed 2022-11-09 | $348.40K derived: sum of 2 quarters · filed 2022-11-09 | $521.10K 10-Q · filed 2022-11-09 | $689.00K derived: sum of 4 quarters · filed 2022-11-09 | ||||
| 2021-06-30 | $174.20K 10-Q · filed 2022-08-10 | $346.90K 10-Q · filed 2022-08-10 | $514.80K derived: sum of 3 quarters · filed 2022-08-10 | $683.40K derived: sum of 4 quarters · filed 2022-08-10 | ||||
| 2021-03-31 | $172.50K 10-Q · filed 2022-05-09 | $340.60K derived: sum of 2 quarters · filed 2022-05-09 | $509.20K derived: sum of 3 quarters · filed 2022-05-09 | $679.30K derived: sum of 4 quarters · filed 2022-05-09 | ||||
| 2020-12-31 | $168.10K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-22 | $336.70K derived: sum of 2 quarters · filed 2022-03-22 | $506.80K derived: sum of 3 quarters · filed 2022-03-22 | $673.90K 10-K · filed 2022-03-22 | ||||
| 2020-09-30 | $168.60K 10-Q · filed 2021-11-10 | $338.70K derived: sum of 2 quarters · filed 2021-11-10 | $505.80K 10-Q · filed 2021-11-10 | |||||
| 2020-06-30 | $170.10K 10-Q · filed 2021-09-13 | $337.20K 10-Q · filed 2021-09-13 | ||||||
| 2019-12-31 | $551.10K 10-K · filed 2022-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |